Ligand profile
ZINC2908852
Virtual-screening candidate from ZINC.
Bound to: VK055_2384 — methionine aminopeptidase, type I
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC2908852- UniProt (similar protein)
P0AE18- Tanimoto
- 0.969
- Target protein
- VK055_2384
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 71.1
- −1 ≤ LogP ≤ 5 2.31
- MW ≤ 500 Da 281.4
- LogP ≤ 5 2.31
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 71.1
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
O=C(Nc1nccs1)C(=O)NC1CCCCCCC1O=C(Nc1nccs1)C(=O)NC1CCCCCCC1
InChI=1S/C13H19N3O2S/c17-11(12(18)16-13-14-8-9-19-13)15-10-6-4-2-1-3-5-7-10/h8-10H,1-7H2,(H,15,17)(H,14,16,18)InChI=1S/C13H19N3O2S/c17-11(12(18)16-13-14-8-9-19-13)15-10-6-4-2-1-3-5-7-10/h8-10H,1-7H2,(H,15,17)(H,14,16,18)
LVBRWMIODCDDBC-UHFFFAOYSA-NLVBRWMIODCDDBC-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Query
- CT0
- Homolog
- P0AE18
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC2908852 →
- ZINC ZINC20 ZINC2908852 →
- UniProt UniProt P0AE18 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC2908852”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_2384.
PDB 46
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).